With new regulations, medtech companies should assess cyber risk - RSM US

Summary

The article discusses the increasing cybersecurity risks for medtech companies, highlighting regulatory requirements from the FDA and SEC, and stressing the importance of robust risk management, including adherence to the NIST Cybersecurity Framework and collaboration with the Basque Cybersecurity Centre, to ensure patient data protection and business continuity. Cyber-Insurance and risk strategies for medical devices are essential in this evolving landscape.